91 related articles for article (PubMed ID: 6201510)
1. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides.
Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A
J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
7. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
8. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
[TBL] [Abstract][Full Text] [Related]
10. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini.
Sankaran H; Goldfine ID; Bailey A; Licko V; Williams JA
Am J Physiol; 1982 Mar; 242(3):G250-7. PubMed ID: 6175228
[TBL] [Abstract][Full Text] [Related]
11. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini.
Sankaran H; Goldfine ID; Deveney CW; Wong KY; Williams JA
J Biol Chem; 1980 Mar; 255(5):1849-53. PubMed ID: 6243650
[TBL] [Abstract][Full Text] [Related]
12. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
13. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
14. Characterization of interactions between CCK-33 and CCK receptors in isolated dispersed pancreatic acini.
Hosotani R; Chowdhury P; Doi R; Rayford PL
J Cell Physiol; 1992 Dec; 153(3):523-7. PubMed ID: 1280279
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of cholecystokinin-stimulated amylase release and cholecystokinin receptor binding in rat pancreatic acini.
Blevins GT; Doi R; Tangoku A; Chowdhury P; McKay D; Rayford PL
J Lab Clin Med; 1992 May; 119(5):566-73. PubMed ID: 1374786
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin antagonists.
Maton PN; Jensen RT; Gardner JD
Horm Metab Res; 1986 Jan; 18(1):2-9. PubMed ID: 2419234
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
Chang RS; Lotti VJ; Chen TB; Kunkel KA
Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
[TBL] [Abstract][Full Text] [Related]
20. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
